Trade

with

Thoratec Corp
(NASDAQ: THOR)
AdChoices
26.51
+0.25
+0.95%
After Hours :
26.51
0.00
0.00%

Open

26.38

Previous Close

26.26

Volume (Avg)

630.56k (1.12M)

Day's Range

26.28-26.96

52Wk Range

22.50-43.58

Market Cap.

1.49B

Dividend Rate ( Yield )

-

Beta

0.79

Shares Outstanding

56.30M

P/E Ratio (EPS)

22.68 (1.17)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • -

    • Net Income

    • -

    • Market Cap.

    • 1.49B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 13.57

    • PEG (Price/Earnings Growth) Ratio

    • 1.15

    • Beta

    • 0.79

    • Forward P/E

    • 17.83

    • Price/Sales

    • 3.08

    • Price/Book Value

    • 2.20

    • Price/Cash flow

    • 13.00

      • EBITDA

      • -

      • Return on Capital %

      • 8.90

      • Return on Equity %

      • 10.19

      • Return on Assets %

      • 8.90

      • Book Value/Share

      • 12.03

      • Shares Outstanding

      • 56.30M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 33.67

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 1.07

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -9.50

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • 30.60

          • -22.64

          • Net Income

            Q/Q (last year)

          • -24.90

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 9.91

          • 4.60

          • Net Income

            5-Year Annual Average

          • 26.60

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 67.53

            • 64.08

            • Pre-Tax Margin

            • 19.03

            • 15.19

            • Net Profit Margin

            • 13.57

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 64.30

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 19.40

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • 12.90

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.34

              • Current Ratio

              • 6.67

              • 2.55

              • Quick Ratio

              • 5.38

              • 1.83

              • Interest Coverage

              • 47,427.00

              • 11.70

              • Leverage Ratio

              • 1.16

              • 1.86

              • Book Value/Share

              • 12.03

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 22.03

                • 34.01

                • P/E Ratio 5-Year High

                • 41.04

                • 224.03

                • P/E Ratio 5-Year Low

                • 19.12

                • 60.23

                • Price/Sales Ratio

                • 2.99

                • 3.17

                • Price/Book Value

                • 2.14

                • 3.20

                • Price/Cash Flow Ratio

                • 13.00

                • 18.42

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 10.19

                    (9.60)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • 8.90

                    (7.60)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 10.19

                    (8.10)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • 65.65k

                  • 34.11k

                  • Inventory Turnover

                  • 2.45

                  • 2.77

                  • Asset Turnover

                  • 0.66

                  • 0.51

                  Current Historical
                  Ownership

                  Institutional Ownership

                  89.64%

                  Top 10 Institutions

                  32.81%

                  Mutual Fund Ownership

                  52.56%

                  Float

                  86.89%

                  5% / Insider Ownership

                  4.09%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Small Cap Index

                  •  

                    977,961

                  • -1.38

                  • 1.74

                  • Vanguard Total Stock Mkt Idx

                  •  

                    916,584

                  • 0.12

                  • 1.63

                  • iShares Russell 2000 (AU)

                  •  

                    879,097

                  • -1.02

                  • 1.53

                  • Wells Fargo Advantage Common Stock Fund

                  •  

                    835,869

                  • 17.94

                  • 1.48

                  • iShares Core S&P Mid-Cap (AU)

                  •  

                    773,212

                  • -2.86

                  • 1.35

                  • Eagle Small Cap Growth Fund

                  •  

                    686,468

                  • -47.75

                  • 1.22

                  • Vanguard Small Cap Growth Index Fund

                  •  

                    660,938

                  • -3.21

                  • 1.17

                  • Pacific Select Fund Mid-Cap Value Port

                  •  

                    633,270

                  • 0.00

                  • 1.12

                  • T. Rowe Price Health Sciences Fund

                  •  

                    626,400

                  • -19.82

                  • 1.11

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Group, Inc.

                  •  

                    3,936,569

                  • -0.11%

                  • 6.99

                  • BlackRock Fund Advisors

                  •  

                    2,617,605

                  • -3.05%

                  • 4.65

                  • State Street Corp

                  •  

                    2,043,035

                  • -0.68%

                  • 3.63

                  • T. Rowe Price Associates, Inc.

                  •  

                    1,732,673

                  • -10.03%

                  • 3.08

                  • Manning & Napier Advisors, LLC

                  •  

                    1,575,340

                  • +138.26%

                  • 2.80

                  • Oracle Investment Management Inc

                  •  

                    1,466,304

                  • -16.51%

                  • 2.60

                  • Wells Capital Management Inc.

                  •  

                    1,383,939

                  • +11.24%

                  • 2.46

                  • Eagle Asset Management, Inc.

                  •  

                    1,348,800

                  • -53.85%

                  • 2.40

                  • BlackRock Advisors LLC

                  •  

                    1,175,338

                  • +72.46%

                  • 2.09

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Aggressive Growth

                  Style

                  Small Core

                  Thoratec Corporation incorporated in the State of California in 1976 provides mechanical circulatory support with a product portfolio to treat the full range of clinical needs for advanced heart failure patients. It develops, manufac...moretures and markets proprietary medical devices used for circulatory support. Following the sale of ITC in 2010, the Company has one operating segment: Cardiovascular group. This segment is organized and operates to develop and manufacture mechanical circulatory products to support the cardiovascular systems of humans. The Company’s VAD products primarily serve patients suffering from late-stage HF. HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level ...moresufficient to meet the body's demands. Hospitals that perform open heart surgery and heart transplants are the potential customers for its Thoratec and HeartMate products. The Company estimates that it sells into 293 of these centers. According to the Company’s estimates, it is in approximately 149 centers in the United States and 144 centers internationally. Competition from medical device companies and medical device divisions of healthcare companies, pharmaceutical companies and gene- and cell-based therapies is intense and is expected to increase. It therefore continues to expect new competitors both from the pharmacological and the medical device space. Among the medical device competitors are Aachen Innovative Solutions GmbH, AbioMed, Inc., Berlin Heart GmbH, HeartWare International Inc., Jarvik Heart, Inc., Maquet Cardiovascular, LLC (a division of Getinge AB), MicroMed Technology, Inc., Sun Medical Technology Research Corporation, SynCardia Systems, Inc., and Terumo Heart, Inc. All of the Company’s proposed products will require regulatory approval prior to commercialization. In particular, medical devices are subject to rigorous pre-clinical testing as a condition of approval by the FDA and by similar authorities in foreign countries.lessless

                  Key People

                  D. Keith Grossman

                  CEO/Director/President

                  Mr. Neil F. Dimick

                  Chairman of the Board/Director

                  Mr. Taylor Harris

                  CFO/Chief Accounting Officer/Vice President

                  J. Daniel Cole

                  Director

                  Paul A. Laviolette

                  Director

                  • Thoratec Corp

                  • 6035 Stoneridge Drive

                  • Pleasanton, CA 94588

                  • USA.Map

                  • Phone: +1 925 847-8600

                  • Fax: +1 925 847-8571

                  • thoratec.com

                  Incorporated

                  1976

                  Employees

                  1,030

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: